Brainomix e-Lung better identifies lung fibrosis patients at risk of decline
Research has shown that Brainomix’s AI-powered e-Lung software can more accurately identify lung fibrosis patients most at risk of decline.
Clinical Software
Brainomix brings its artificial intelligence technology to TIPAL trial
Brainomix will be trialling its novel imaging biomarkers in its e-Lung platform as a sub-study of the TIPAL trial for idiopathic pulmonary fibrosis.
AI and Analytics